Skip to main content

Eliahu Heldman, PhD

Chief Scientific Officer at Lauren Sciences, LLC

Dr. Eliahu Heldman is CSO of Lauren Sciences LLC, and professor emeritus at Ben-Gurion University, with over 40 years experience in neuroscience research. Dr. Heldman, and Drs. Sarina Grinberg and Charles Linder, are credited with the V-SmartTM invention, patents, publications and grants from US-Israel Binational Science Foundation and Israel Science Foundation. Dr. Heldman oversees further development of V-SmartTM. Dr. Heldman’s experience includes work at NIH, evaluation of CNS-active drugs at Israel Institute for Biological Research, director of cell biology at V.I. Technologies, New York and a founder in 2003 of NeuroDerm Ltd., Israel that received two grants from MJFF for a Parkinson's treatment now in clinical trials. Dr. Heldman was a co-inventor of Cevimeline (EvoxacTM), a muscarinic agonist, FDA-approved for treatment of Sjogren's syndrome. Professor Heldman published over 130 scientific articles, is co-inventor on more than 10 patents and was editor of two books on neuroactive drugs.


Associated Grants

  • Delivery of GDNF to the Brain by Novel Nanovesicles for the Treatment of Parkinson’s Disease (Supplement)


  • Delivery of GDNF to the Brain by Novel Nanovesicles for the Treatment of PD


  • Alleviating late motor complications of Parkinson's disease by a continuous dopaminergic treatment with transdermal delivery of L-DOPA Pro-drug


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.